Biotech | April 20, 2022
MicroGEM granted EUA for Covid-19 PCR Saliva test
The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes
The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes
New product line to address the challenge of restrictions on use of plastic straws
The HD-550 endoscopy system has been available outside of the USA since 2019
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors
This product will be manufactured at Lupin’s Nagpur facility in India
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
The product will be manufactured at Lupin’s facility in Goa, India
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
This product is indicated for the short-term treatment of a breathing problem (apnea) in premature infants
Subscribe To Our Newsletter & Stay Updated
